These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 21605926

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Computational discovery of novel trypanosomicidal drug-like chemicals by using bond-based non-stochastic and stochastic quadratic maps and linear discriminant analysis.
    Castillo-Garit JA, Vega MC, Rolon M, Marrero-Ponce Y, Kouznetsov VV, Torres DF, Gómez-Barrio A, Bello AA, Montero A, Torrens F, Pérez-Giménez F.
    Eur J Pharm Sci; 2010 Jan 31; 39(1-3):30-6. PubMed ID: 19854271
    [Abstract] [Full Text] [Related]

  • 3. Identification in silico and in vitro of novel trypanosomicidal drug-like compounds.
    Castillo-Garit JA, Del Toro-Cortés O, Kouznetsov VV, Puentes CO, Romero Bohórquez AR, Vega MC, Rolón M, Escario JA, Gómez-Barrio A, Marrero-Ponce Y, Torrens F, Abad C.
    Chem Biol Drug Des; 2012 Jul 31; 80(1):38-45. PubMed ID: 22405194
    [Abstract] [Full Text] [Related]

  • 4. Bond-based bilinear indices for computational discovery of novel trypanosomicidal drug-like compounds through virtual screening.
    Castillo-Garit JA, del Toro-Cortés O, Vega MC, Rolón M, Rojas de Arias A, Casañola-Martin GM, Escario JA, Gómez-Barrio A, Marrero-Ponce Y, Torrens F, Abad C.
    Eur J Med Chem; 2015 Jul 31; 96():238-44. PubMed ID: 25884114
    [Abstract] [Full Text] [Related]

  • 5. Discovery of novel anti-inflammatory drug-like compounds by aligning in silico and in vivo screening: the nitroindazolinone chemotype.
    Marrero-Ponce Y, Siverio-Mota D, Gálvez-Llompart M, Recio MC, Giner RM, García-Domènech R, Torrens F, Arán VJ, Cordero-Maldonado ML, Esguera CV, de Witte PA, Crawford AD.
    Eur J Med Chem; 2011 Dec 31; 46(12):5736-53. PubMed ID: 22000935
    [Abstract] [Full Text] [Related]

  • 6. Activity of "reversed" diamidines against Trypanosoma cruzi "in vitro".
    Silva CF, Batista MM, Mota RA, de Souza EM, Stephens CE, Som P, Boykin DW, Soeiro Mde N.
    Biochem Pharmacol; 2007 Jun 15; 73(12):1939-46. PubMed ID: 17462605
    [Abstract] [Full Text] [Related]

  • 7. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y, Iyarreta-Veitía M, Montero-Torres A, Romero-Zaldivar C, Brandt CA, Avila PE, Kirchgatter K, Machado Y.
    J Chem Inf Model; 2005 Jun 15; 45(4):1082-100. PubMed ID: 16045304
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Atom- and bond-based 2D TOMOCOMD-CARDD approach and ligand-based virtual screening for the drug discovery of new tyrosinase inhibitors.
    Casañola-Martín GM, Marrero-Ponce Y, Tareq Hassan Khan M, Torrens F, Pérez-Giménez F, Rescigno A.
    J Biomol Screen; 2008 Dec 15; 13(10):1014-24. PubMed ID: 19015291
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Trypanosoma cruzi: in vitro activity of Epoxy-alpha-Lap, a derivative of alpha-lapachone, on trypomastigote and amastigote forms.
    Bourguignon SC, Castro HC, Santos DO, Alves CR, Ferreira VF, Gama IL, Silva FC, Seguins WS, Pinho RT.
    Exp Parasitol; 2009 Jun 15; 122(2):91-6. PubMed ID: 19285074
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices.
    Casañola-Martín GM, Marrero-Ponce Y, Khan MT, Ather A, Sultan S, Torrens F, Rotondo R.
    Bioorg Med Chem; 2007 Feb 01; 15(3):1483-503. PubMed ID: 17110117
    [Abstract] [Full Text] [Related]

  • 15. Anti-T. cruzi activities and QSAR studies of 3-arylquinoxaline-2-carbonitrile di-N-oxides.
    Vicente E, Duchowicz PR, Benítez D, Castro EA, Cerecetto H, González M, Monge A.
    Bioorg Med Chem Lett; 2010 Aug 15; 20(16):4831-5. PubMed ID: 20634064
    [Abstract] [Full Text] [Related]

  • 16. Investigating the structure-activity relationships of N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds.
    Palace-Berl F, Pasqualoto KFM, Zingales B, Moraes CB, Bury M, Franco CH, da Silva Neto AL, Murayama JS, Nunes SL, Silva MN, Tavares LC.
    Eur J Med Chem; 2018 Jan 20; 144():29-40. PubMed ID: 29247858
    [Abstract] [Full Text] [Related]

  • 17. Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi.
    Ribeiro TS, Freire-de-Lima L, Previato JO, Mendonça-Previato L, Heise N, de Lima ME.
    Bioorg Med Chem Lett; 2004 Jul 05; 14(13):3555-8. PubMed ID: 15177472
    [Abstract] [Full Text] [Related]

  • 18. New ligand-based approach for the discovery of antitrypanosomal compounds.
    Vega MC, Montero-Torres A, Marrero-Ponce Y, Rolón M, Gómez-Barrio A, Escario JA, Arán VJ, Nogal JJ, Meneses-Marcel A, Torrens F.
    Bioorg Med Chem Lett; 2006 Apr 01; 16(7):1898-904. PubMed ID: 16455249
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and biological characterization of new aryloxyindole-4,9-diones as potent trypanosomicidal agents.
    Tapia RA, Salas CO, Vázquez K, Espinosa-Bustos C, Soto-Delgado J, Varela J, Birriel E, Cerecetto H, González M, Paulino M.
    Bioorg Med Chem Lett; 2014 Aug 15; 24(16):3919-22. PubMed ID: 25008454
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo trypanocidal activity of flavonoids from Delphinium staphisagria against Chagas disease.
    Marín C, Ramírez-Macías I, López-Céspedes A, Olmo F, Villegas N, Díaz JG, Rosales MJ, Gutiérrez-Sánchez R, Sánchez-Moreno M.
    J Nat Prod; 2011 Apr 25; 74(4):744-50. PubMed ID: 21466157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.